"Our leadership in venture capital is reinforced as more entrepreneurs apply to Sanabil Accelerator by 500 Global, seeking support to develop their ideas and achieve success at home and ... and ...

“The success of Enhertu has put a new kind of feeling into this space," he said. "In 2013, there were 32 trials in this space. Last year there were over 300 [...] So, something that was thought ...

Daiichi Sankyo has been ordered to pay an 8% royalty rate on sales of its breast cancer therapy Enhertu by a Texas court, on top of an earlier award of $41.8 million in damages, in an ongoing ...

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies ...